Loading insider details...
Latest Form 4 (Jul 2, 2026): Exercise/Conversion of 61,378 KYMR shares, $327.1K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 2, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 61,378 | $327.1K |
| Jun 3, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 12,653 | $26.3K |
| May 19, 2026 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 15,000 | $31.2K |
| Mar 4, 2026 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 17,650 | n/a |
| Sep 17, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 79,220 | $164.8K |
| Apr 1, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 25,000 | $52.0K |
| Mar 3, 2025 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 30,000 | n/a |
| Jan 13, 2025 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 10,000 | $20.8K |
| Jun 28, 2024 | Kymera Therapeutics, Inc. (KYMR) | Exercise/Conversion | 25,000 | $52.0K |
| Mar 4, 2024 | Kymera Therapeutics, Inc. (KYMR) | Grant/Award | 31,250 | n/a |